Advertisement

Index by author

February 01, 2002; Volume 30,Issue 2

A

  1. Abe, Takaaki

    1. Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates
      Daisuke Sugiyama, Hiroyuki Kusuhara, Yoshihisa Shitara, Takaaki Abe and Yuichi Sugiyama
      Drug Metabolism and Disposition February 2002, 30 (2) 220-223; DOI: https://doi.org/10.1124/dmd.30.2.220

  2. Addison, R. S.

    1. Conjugation of Desmethylnaproxen in the Rat—A Novel Acyl Glucuronide-Sulfate Diconjugate as a Major Biliary Metabolite
      R. Jaggi, R. S. Addison, A. R. King, B. D. Suthers and R. G. Dickinson
      Drug Metabolism and Disposition February 2002, 30 (2) 161-166; DOI: https://doi.org/10.1124/dmd.30.2.161

  3. Aktas, Mehmet K.

    1. Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs
      Peter D. Sadowitz, Bradley A. Hubbard, James C. Dabrowiak, Jerry Goodisman, Kirk A. Tacka, Mehmet K. Aktas, Mary J. Cunningham, Ronald L. Dubowy and Abdul-Kader Souid
      Drug Metabolism and Disposition February 2002, 30 (2) 183-190; DOI: https://doi.org/10.1124/dmd.30.2.183

  4. Altuntas, T. Gul

    1. Biotransformation of l-CysteineS-Conjugates andN-Acetyl-l-CysteineS-Conjugates of the Sevoflurane Degradation Product Fluoromethyl-2,2-Difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Human Kidney in Vitro: Interindividual Variability inN-Acetylation, N-Deacetylation, and β-Lyase-Catalyzed Metabolism
      T. Gul Altuntas and Evan D. Kharasch
      Drug Metabolism and Disposition February 2002, 30 (2) 148-154; DOI: https://doi.org/10.1124/dmd.30.2.148

  5. Anderson, Bradley D.

    1. Investigation of the Mechanism of Enhancement of Central Nervous System Delivery of 2′-β-Fluoro-2′,3′-Dideoxyinosine Via a Blood-Brain Barrier Adenosine Deaminase-Activated Prodrug
      Mark D. Johnson, Jian Chen and Bradley D. Anderson
      Drug Metabolism and Disposition February 2002, 30 (2) 191-198; DOI: https://doi.org/10.1124/dmd.30.2.191

  6. Antonio, Laurence

    1. Characterization of Catechol Glucuronidation in Rat Liver
      Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou
      Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199

B

  1. Bauman, Jonathan N.

    1. The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs
      Jasminder Sahi, Eric L. Reyner, Jonathan N. Bauman, Kristina Gueneva-Boucheva, James E. Burleigh and V. Hayden Thomas
      Drug Metabolism and Disposition February 2002, 30 (2) 135-140; DOI: https://doi.org/10.1124/dmd.30.2.135

  2. Benoit, Etienne

    1. Cloning, Sequencing, and Tissue-Dependent Expression of Flavin-Containing Monooxygenase (FMO) 1 and FMO3 in the Dog
      Virginie Lattard, Christiane Longin-Sauvageon, Joel Lachuer, Paul Delatour and Etienne Benoit
      Drug Metabolism and Disposition February 2002, 30 (2) 119-128; DOI: https://doi.org/10.1124/dmd.30.2.119

  3. Bruelisauer, Armin

    1. Brain Pharmacokinetics of a Nonpeptidic Corticotropin-Releasing Factor Receptor Antagonist
      Caroline Keller, Armin Bruelisauer, Michel Lemaire and Albert Enz
      Drug Metabolism and Disposition February 2002, 30 (2) 173-176; DOI: https://doi.org/10.1124/dmd.30.2.173

  4. Burchell, Brian

    1. Characterization of Catechol Glucuronidation in Rat Liver
      Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou
      Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199

  5. Burleigh, James E.

    1. The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs
      Jasminder Sahi, Eric L. Reyner, Jonathan N. Bauman, Kristina Gueneva-Boucheva, James E. Burleigh and V. Hayden Thomas
      Drug Metabolism and Disposition February 2002, 30 (2) 135-140; DOI: https://doi.org/10.1124/dmd.30.2.135

C

  1. Chen, Jian

    1. Investigation of the Mechanism of Enhancement of Central Nervous System Delivery of 2′-β-Fluoro-2′,3′-Dideoxyinosine Via a Blood-Brain Barrier Adenosine Deaminase-Activated Prodrug
      Mark D. Johnson, Jian Chen and Bradley D. Anderson
      Drug Metabolism and Disposition February 2002, 30 (2) 191-198; DOI: https://doi.org/10.1124/dmd.30.2.191

  2. Cherrington, N. J.

    1. Tissue Distribution and Renal Developmental Changes in Rat Organic Cation Transporter mRNA levels
      A. L. Slitt, N. J. Cherrington, D. P. Hartley, T. M. Leazer and C. D. Klaassen
      Drug Metabolism and Disposition February 2002, 30 (2) 212-219; DOI: https://doi.org/10.1124/dmd.30.2.212

  3. Congiu, Mario

    1. UDP Glucuronosyltransferase mRNA Levels in Human Liver Disease
      Mario Congiu, Maurice L. Mashford, John L. Slavin and Paul V. Desmond
      Drug Metabolism and Disposition February 2002, 30 (2) 129-134; DOI: https://doi.org/10.1124/dmd.30.2.129

  4. Cunningham, Mary J.

    1. Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs
      Peter D. Sadowitz, Bradley A. Hubbard, James C. Dabrowiak, Jerry Goodisman, Kirk A. Tacka, Mehmet K. Aktas, Mary J. Cunningham, Ronald L. Dubowy and Abdul-Kader Souid
      Drug Metabolism and Disposition February 2002, 30 (2) 183-190; DOI: https://doi.org/10.1124/dmd.30.2.183

D

  1. Dabrowiak, James C.

    1. Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs
      Peter D. Sadowitz, Bradley A. Hubbard, James C. Dabrowiak, Jerry Goodisman, Kirk A. Tacka, Mehmet K. Aktas, Mary J. Cunningham, Ronald L. Dubowy and Abdul-Kader Souid
      Drug Metabolism and Disposition February 2002, 30 (2) 183-190; DOI: https://doi.org/10.1124/dmd.30.2.183

  2. Delatour, Paul

    1. Cloning, Sequencing, and Tissue-Dependent Expression of Flavin-Containing Monooxygenase (FMO) 1 and FMO3 in the Dog
      Virginie Lattard, Christiane Longin-Sauvageon, Joel Lachuer, Paul Delatour and Etienne Benoit
      Drug Metabolism and Disposition February 2002, 30 (2) 119-128; DOI: https://doi.org/10.1124/dmd.30.2.119

  3. Delbressine, L. P. C.

    1. The in Vivo Human Metabolism of Tibolone
      R. M. E. Vos, S. F. M. Krebbers, C. H. J. Verhoeven and L. P. C. Delbressine
      Drug Metabolism and Disposition February 2002, 30 (2) 106-112; DOI: https://doi.org/10.1124/dmd.30.2.106

  4. Desmond, Paul V.

    1. UDP Glucuronosyltransferase mRNA Levels in Human Liver Disease
      Mario Congiu, Maurice L. Mashford, John L. Slavin and Paul V. Desmond
      Drug Metabolism and Disposition February 2002, 30 (2) 129-134; DOI: https://doi.org/10.1124/dmd.30.2.129

  5. Dhir, Ravindra N.

    1. Middle-Age Alterations in the Sexually Dimorphic Plasma Growth Hormone Profiles: Involvement of Growth Hormone-Releasing Factor and Effects on Cytochrome P450 Expression
      Ravindra N. Dhir, Wojciech Dworakowski and Bernard H. Shapiro
      Drug Metabolism and Disposition February 2002, 30 (2) 141-147; DOI: https://doi.org/10.1124/dmd.30.2.141

  6. Dickinson, R. G.

    1. Conjugation of Desmethylnaproxen in the Rat—A Novel Acyl Glucuronide-Sulfate Diconjugate as a Major Biliary Metabolite
      R. Jaggi, R. S. Addison, A. R. King, B. D. Suthers and R. G. Dickinson
      Drug Metabolism and Disposition February 2002, 30 (2) 161-166; DOI: https://doi.org/10.1124/dmd.30.2.161

  7. Dubowy, Ronald L.

    1. Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs
      Peter D. Sadowitz, Bradley A. Hubbard, James C. Dabrowiak, Jerry Goodisman, Kirk A. Tacka, Mehmet K. Aktas, Mary J. Cunningham, Ronald L. Dubowy and Abdul-Kader Souid
      Drug Metabolism and Disposition February 2002, 30 (2) 183-190; DOI: https://doi.org/10.1124/dmd.30.2.183

  8. Dworakowski, Wojciech

    1. Middle-Age Alterations in the Sexually Dimorphic Plasma Growth Hormone Profiles: Involvement of Growth Hormone-Releasing Factor and Effects on Cytochrome P450 Expression
      Ravindra N. Dhir, Wojciech Dworakowski and Bernard H. Shapiro
      Drug Metabolism and Disposition February 2002, 30 (2) 141-147; DOI: https://doi.org/10.1124/dmd.30.2.141

E

  1. Elovaara, Eivor

    1. Characterization of Catechol Glucuronidation in Rat Liver
      Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou
      Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199

  2. Enz, Albert

    1. Brain Pharmacokinetics of a Nonpeptidic Corticotropin-Releasing Factor Receptor Antagonist
      Caroline Keller, Armin Bruelisauer, Michel Lemaire and Albert Enz
      Drug Metabolism and Disposition February 2002, 30 (2) 173-176; DOI: https://doi.org/10.1124/dmd.30.2.173

  3. Ethell, Brian

    1. Characterization of Catechol Glucuronidation in Rat Liver
      Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou
      Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199

F

  1. Fournel-Gigleux, Sylvie

    1. Characterization of Catechol Glucuronidation in Rat Liver
      Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou
      Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199

  2. Franklin, Michael R.

    1. The Influence of l-Glutamine on the Depression of Hepatic Cytochrome P450 Activity in Male Rats Caused by Total Parenteral Nutrition
      Andrew A. Shaw, Stephen D. Hall, Michael R. Franklin and Raymond E. Galinsky
      Drug Metabolism and Disposition February 2002, 30 (2) 177-182; DOI: https://doi.org/10.1124/dmd.30.2.177

G

  1. Galinsky, Raymond E.

    1. The Influence of l-Glutamine on the Depression of Hepatic Cytochrome P450 Activity in Male Rats Caused by Total Parenteral Nutrition
      Andrew A. Shaw, Stephen D. Hall, Michael R. Franklin and Raymond E. Galinsky
      Drug Metabolism and Disposition February 2002, 30 (2) 177-182; DOI: https://doi.org/10.1124/dmd.30.2.177

  2. Goodisman, Jerry

    1. Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs
      Peter D. Sadowitz, Bradley A. Hubbard, James C. Dabrowiak, Jerry Goodisman, Kirk A. Tacka, Mehmet K. Aktas, Mary J. Cunningham, Ronald L. Dubowy and Abdul-Kader Souid
      Drug Metabolism and Disposition February 2002, 30 (2) 183-190; DOI: https://doi.org/10.1124/dmd.30.2.183

  3. Grillasca, Joël-Paul

    1. Characterization of Catechol Glucuronidation in Rat Liver
      Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou
      Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199

  4. Gueneva-Boucheva, Kristina

    1. The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs
      Jasminder Sahi, Eric L. Reyner, Jonathan N. Bauman, Kristina Gueneva-Boucheva, James E. Burleigh and V. Hayden Thomas
      Drug Metabolism and Disposition February 2002, 30 (2) 135-140; DOI: https://doi.org/10.1124/dmd.30.2.135

H

  1. Hall, Stephen D.

    1. The Influence of l-Glutamine on the Depression of Hepatic Cytochrome P450 Activity in Male Rats Caused by Total Parenteral Nutrition
      Andrew A. Shaw, Stephen D. Hall, Michael R. Franklin and Raymond E. Galinsky
      Drug Metabolism and Disposition February 2002, 30 (2) 177-182; DOI: https://doi.org/10.1124/dmd.30.2.177

  2. Hartley, D. P.

    1. Tissue Distribution and Renal Developmental Changes in Rat Organic Cation Transporter mRNA levels
      A. L. Slitt, N. J. Cherrington, D. P. Hartley, T. M. Leazer and C. D. Klaassen
      Drug Metabolism and Disposition February 2002, 30 (2) 212-219; DOI: https://doi.org/10.1124/dmd.30.2.212

  3. Honma, Seijirou

    1. Pharmacokinetics and Biliary Excretion of Osaterone Acetate, a New Steroidal Antiandrogen, in Dogs
      Kouichi Minato, Naoyuki Koizumi, Seijirou Honma, Kunio Tsukamoto and Satoshi Iwamura
      Drug Metabolism and Disposition February 2002, 30 (2) 167-172; DOI: https://doi.org/10.1124/dmd.30.2.167

  4. Hubbard, Bradley A.

    1. Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs
      Peter D. Sadowitz, Bradley A. Hubbard, James C. Dabrowiak, Jerry Goodisman, Kirk A. Tacka, Mehmet K. Aktas, Mary J. Cunningham, Ronald L. Dubowy and Abdul-Kader Souid
      Drug Metabolism and Disposition February 2002, 30 (2) 183-190; DOI: https://doi.org/10.1124/dmd.30.2.183

I

  1. Ikeda, Tomoko

    1. Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells
      Yui Yamamoto, Hiroshi Yamazaki, Tomoko Ikeda, Terumi Watanabe, Haruo Iwabuchi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition February 2002, 30 (2) 155-160; DOI: https://doi.org/10.1124/dmd.30.2.155

  2. Iwabuchi, Haruo

    1. Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells
      Yui Yamamoto, Hiroshi Yamazaki, Tomoko Ikeda, Terumi Watanabe, Haruo Iwabuchi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition February 2002, 30 (2) 155-160; DOI: https://doi.org/10.1124/dmd.30.2.155

  3. Iwamura, Satoshi

    1. Pharmacokinetics and Biliary Excretion of Osaterone Acetate, a New Steroidal Antiandrogen, in Dogs
      Kouichi Minato, Naoyuki Koizumi, Seijirou Honma, Kunio Tsukamoto and Satoshi Iwamura
      Drug Metabolism and Disposition February 2002, 30 (2) 167-172; DOI: https://doi.org/10.1124/dmd.30.2.167

J

  1. Jaggi, R.

    1. Conjugation of Desmethylnaproxen in the Rat—A Novel Acyl Glucuronide-Sulfate Diconjugate as a Major Biliary Metabolite
      R. Jaggi, R. S. Addison, A. R. King, B. D. Suthers and R. G. Dickinson
      Drug Metabolism and Disposition February 2002, 30 (2) 161-166; DOI: https://doi.org/10.1124/dmd.30.2.161

  2. Johnson, Mark D.

    1. Investigation of the Mechanism of Enhancement of Central Nervous System Delivery of 2′-β-Fluoro-2′,3′-Dideoxyinosine Via a Blood-Brain Barrier Adenosine Deaminase-Activated Prodrug
      Mark D. Johnson, Jian Chen and Bradley D. Anderson
      Drug Metabolism and Disposition February 2002, 30 (2) 191-198; DOI: https://doi.org/10.1124/dmd.30.2.191

K

  1. Kakizaki, Satoru

    1. Retinoic Acids Repress Constitutive Active Receptor-Mediated Induction by 1,4-bis[2-(3,5-Dichloropyridyloxy)]benzene of theCyp2b10 Gene in Mouse Primary Hepatocytes
      Satoru Kakizaki, Sohrab Karami and Masahiko Negishi
      Drug Metabolism and Disposition February 2002, 30 (2) 208-211; DOI: https://doi.org/10.1124/dmd.30.2.208

  2. Karami, Sohrab

    1. Retinoic Acids Repress Constitutive Active Receptor-Mediated Induction by 1,4-bis[2-(3,5-Dichloropyridyloxy)]benzene of theCyp2b10 Gene in Mouse Primary Hepatocytes
      Satoru Kakizaki, Sohrab Karami and Masahiko Negishi
      Drug Metabolism and Disposition February 2002, 30 (2) 208-211; DOI: https://doi.org/10.1124/dmd.30.2.208

  3. Keller, Caroline

    1. Brain Pharmacokinetics of a Nonpeptidic Corticotropin-Releasing Factor Receptor Antagonist
      Caroline Keller, Armin Bruelisauer, Michel Lemaire and Albert Enz
      Drug Metabolism and Disposition February 2002, 30 (2) 173-176; DOI: https://doi.org/10.1124/dmd.30.2.173

  4. Kharasch, Evan D.

    1. Biotransformation of l-CysteineS-Conjugates andN-Acetyl-l-CysteineS-Conjugates of the Sevoflurane Degradation Product Fluoromethyl-2,2-Difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Human Kidney in Vitro: Interindividual Variability inN-Acetylation, N-Deacetylation, and β-Lyase-Catalyzed Metabolism
      T. Gul Altuntas and Evan D. Kharasch
      Drug Metabolism and Disposition February 2002, 30 (2) 148-154; DOI: https://doi.org/10.1124/dmd.30.2.148

  5. King, A. R.

    1. Conjugation of Desmethylnaproxen in the Rat—A Novel Acyl Glucuronide-Sulfate Diconjugate as a Major Biliary Metabolite
      R. Jaggi, R. S. Addison, A. R. King, B. D. Suthers and R. G. Dickinson
      Drug Metabolism and Disposition February 2002, 30 (2) 161-166; DOI: https://doi.org/10.1124/dmd.30.2.161

  6. Kitamura, Shigeyuki

    1. Reductive Metabolism ofp,p′-DDT ando,p′-DDT by Rat Liver Cytochrome P450
      Shigeyuki Kitamura, Yuri Shimizu, Yuko Shiraga, Mayumi Yoshida, Kazumi Sugihara and Shigeru Ohta
      Drug Metabolism and Disposition February 2002, 30 (2) 113-118; DOI: https://doi.org/10.1124/dmd.30.2.113

  7. Klaassen, C. D.

    1. Tissue Distribution and Renal Developmental Changes in Rat Organic Cation Transporter mRNA levels
      A. L. Slitt, N. J. Cherrington, D. P. Hartley, T. M. Leazer and C. D. Klaassen
      Drug Metabolism and Disposition February 2002, 30 (2) 212-219; DOI: https://doi.org/10.1124/dmd.30.2.212

  8. Koizumi, Naoyuki

    1. Pharmacokinetics and Biliary Excretion of Osaterone Acetate, a New Steroidal Antiandrogen, in Dogs
      Kouichi Minato, Naoyuki Koizumi, Seijirou Honma, Kunio Tsukamoto and Satoshi Iwamura
      Drug Metabolism and Disposition February 2002, 30 (2) 167-172; DOI: https://doi.org/10.1124/dmd.30.2.167

  9. Krebbers, S. F. M.

    1. The in Vivo Human Metabolism of Tibolone
      R. M. E. Vos, S. F. M. Krebbers, C. H. J. Verhoeven and L. P. C. Delbressine
      Drug Metabolism and Disposition February 2002, 30 (2) 106-112; DOI: https://doi.org/10.1124/dmd.30.2.106

  10. Kusuhara, Hiroyuki

    1. Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates
      Daisuke Sugiyama, Hiroyuki Kusuhara, Yoshihisa Shitara, Takaaki Abe and Yuichi Sugiyama
      Drug Metabolism and Disposition February 2002, 30 (2) 220-223; DOI: https://doi.org/10.1124/dmd.30.2.220

L

  1. Lachuer, Joel

    1. Cloning, Sequencing, and Tissue-Dependent Expression of Flavin-Containing Monooxygenase (FMO) 1 and FMO3 in the Dog
      Virginie Lattard, Christiane Longin-Sauvageon, Joel Lachuer, Paul Delatour and Etienne Benoit
      Drug Metabolism and Disposition February 2002, 30 (2) 119-128; DOI: https://doi.org/10.1124/dmd.30.2.119

  2. Lattard, Virginie

    1. Cloning, Sequencing, and Tissue-Dependent Expression of Flavin-Containing Monooxygenase (FMO) 1 and FMO3 in the Dog
      Virginie Lattard, Christiane Longin-Sauvageon, Joel Lachuer, Paul Delatour and Etienne Benoit
      Drug Metabolism and Disposition February 2002, 30 (2) 119-128; DOI: https://doi.org/10.1124/dmd.30.2.119

  3. Leazer, T. M.

    1. Tissue Distribution and Renal Developmental Changes in Rat Organic Cation Transporter mRNA levels
      A. L. Slitt, N. J. Cherrington, D. P. Hartley, T. M. Leazer and C. D. Klaassen
      Drug Metabolism and Disposition February 2002, 30 (2) 212-219; DOI: https://doi.org/10.1124/dmd.30.2.212

  4. Lemaire, Michel

    1. Brain Pharmacokinetics of a Nonpeptidic Corticotropin-Releasing Factor Receptor Antagonist
      Caroline Keller, Armin Bruelisauer, Michel Lemaire and Albert Enz
      Drug Metabolism and Disposition February 2002, 30 (2) 173-176; DOI: https://doi.org/10.1124/dmd.30.2.173

  5. Longin-Sauvageon, Christiane

    1. Cloning, Sequencing, and Tissue-Dependent Expression of Flavin-Containing Monooxygenase (FMO) 1 and FMO3 in the Dog
      Virginie Lattard, Christiane Longin-Sauvageon, Joel Lachuer, Paul Delatour and Etienne Benoit
      Drug Metabolism and Disposition February 2002, 30 (2) 119-128; DOI: https://doi.org/10.1124/dmd.30.2.119

M

  1. Magdalou, Jacques

    1. Characterization of Catechol Glucuronidation in Rat Liver
      Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou
      Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199

  2. Mashford, Maurice L.

    1. UDP Glucuronosyltransferase mRNA Levels in Human Liver Disease
      Mario Congiu, Maurice L. Mashford, John L. Slavin and Paul V. Desmond
      Drug Metabolism and Disposition February 2002, 30 (2) 129-134; DOI: https://doi.org/10.1124/dmd.30.2.129

  3. Minato, Kouichi

    1. Pharmacokinetics and Biliary Excretion of Osaterone Acetate, a New Steroidal Antiandrogen, in Dogs
      Kouichi Minato, Naoyuki Koizumi, Seijirou Honma, Kunio Tsukamoto and Satoshi Iwamura
      Drug Metabolism and Disposition February 2002, 30 (2) 167-172; DOI: https://doi.org/10.1124/dmd.30.2.167

N

  1. Nakajima, Miki

    1. Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells
      Yui Yamamoto, Hiroshi Yamazaki, Tomoko Ikeda, Terumi Watanabe, Haruo Iwabuchi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition February 2002, 30 (2) 155-160; DOI: https://doi.org/10.1124/dmd.30.2.155

  2. Negishi, Masahiko

    1. Retinoic Acids Repress Constitutive Active Receptor-Mediated Induction by 1,4-bis[2-(3,5-Dichloropyridyloxy)]benzene of theCyp2b10 Gene in Mouse Primary Hepatocytes
      Satoru Kakizaki, Sohrab Karami and Masahiko Negishi
      Drug Metabolism and Disposition February 2002, 30 (2) 208-211; DOI: https://doi.org/10.1124/dmd.30.2.208

O

  1. Ohta, Shigeru

    1. Reductive Metabolism ofp,p′-DDT ando,p′-DDT by Rat Liver Cytochrome P450
      Shigeyuki Kitamura, Yuri Shimizu, Yuko Shiraga, Mayumi Yoshida, Kazumi Sugihara and Shigeru Ohta
      Drug Metabolism and Disposition February 2002, 30 (2) 113-118; DOI: https://doi.org/10.1124/dmd.30.2.113

  2. Otake, Yoko

    1. Oxidation of the Flavonoids Galangin and Kaempferide by Human Liver Microsomes and CYP1A1, CYP1A2, and CYP2C9
      Yoko Otake and Thomas Walle
      Drug Metabolism and Disposition February 2002, 30 (2) 103-105; DOI: https://doi.org/10.1124/dmd.30.2.103

  3. Ouzzine, Mohamed

    1. Characterization of Catechol Glucuronidation in Rat Liver
      Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou
      Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199

P

  1. Piet, Marie-Helene

    1. Characterization of Catechol Glucuronidation in Rat Liver
      Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou
      Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199

R

  1. Reyner, Eric L.

    1. The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs
      Jasminder Sahi, Eric L. Reyner, Jonathan N. Bauman, Kristina Gueneva-Boucheva, James E. Burleigh and V. Hayden Thomas
      Drug Metabolism and Disposition February 2002, 30 (2) 135-140; DOI: https://doi.org/10.1124/dmd.30.2.135

S

  1. Sadowitz, Peter D.

    1. Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs
      Peter D. Sadowitz, Bradley A. Hubbard, James C. Dabrowiak, Jerry Goodisman, Kirk A. Tacka, Mehmet K. Aktas, Mary J. Cunningham, Ronald L. Dubowy and Abdul-Kader Souid
      Drug Metabolism and Disposition February 2002, 30 (2) 183-190; DOI: https://doi.org/10.1124/dmd.30.2.183

  2. Sahi, Jasminder

    1. The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs
      Jasminder Sahi, Eric L. Reyner, Jonathan N. Bauman, Kristina Gueneva-Boucheva, James E. Burleigh and V. Hayden Thomas
      Drug Metabolism and Disposition February 2002, 30 (2) 135-140; DOI: https://doi.org/10.1124/dmd.30.2.135

  3. Shapiro, Bernard H.

    1. Middle-Age Alterations in the Sexually Dimorphic Plasma Growth Hormone Profiles: Involvement of Growth Hormone-Releasing Factor and Effects on Cytochrome P450 Expression
      Ravindra N. Dhir, Wojciech Dworakowski and Bernard H. Shapiro
      Drug Metabolism and Disposition February 2002, 30 (2) 141-147; DOI: https://doi.org/10.1124/dmd.30.2.141

  4. Shaw, Andrew A.

    1. The Influence of l-Glutamine on the Depression of Hepatic Cytochrome P450 Activity in Male Rats Caused by Total Parenteral Nutrition
      Andrew A. Shaw, Stephen D. Hall, Michael R. Franklin and Raymond E. Galinsky
      Drug Metabolism and Disposition February 2002, 30 (2) 177-182; DOI: https://doi.org/10.1124/dmd.30.2.177

  5. Shimizu, Yuri

    1. Reductive Metabolism ofp,p′-DDT ando,p′-DDT by Rat Liver Cytochrome P450
      Shigeyuki Kitamura, Yuri Shimizu, Yuko Shiraga, Mayumi Yoshida, Kazumi Sugihara and Shigeru Ohta
      Drug Metabolism and Disposition February 2002, 30 (2) 113-118; DOI: https://doi.org/10.1124/dmd.30.2.113

  6. Shiraga, Yuko

    1. Reductive Metabolism ofp,p′-DDT ando,p′-DDT by Rat Liver Cytochrome P450
      Shigeyuki Kitamura, Yuri Shimizu, Yuko Shiraga, Mayumi Yoshida, Kazumi Sugihara and Shigeru Ohta
      Drug Metabolism and Disposition February 2002, 30 (2) 113-118; DOI: https://doi.org/10.1124/dmd.30.2.113

  7. Shitara, Yoshihisa

    1. Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates
      Daisuke Sugiyama, Hiroyuki Kusuhara, Yoshihisa Shitara, Takaaki Abe and Yuichi Sugiyama
      Drug Metabolism and Disposition February 2002, 30 (2) 220-223; DOI: https://doi.org/10.1124/dmd.30.2.220

  8. Slavin, John L.

    1. UDP Glucuronosyltransferase mRNA Levels in Human Liver Disease
      Mario Congiu, Maurice L. Mashford, John L. Slavin and Paul V. Desmond
      Drug Metabolism and Disposition February 2002, 30 (2) 129-134; DOI: https://doi.org/10.1124/dmd.30.2.129

  9. Slitt, A. L.

    1. Tissue Distribution and Renal Developmental Changes in Rat Organic Cation Transporter mRNA levels
      A. L. Slitt, N. J. Cherrington, D. P. Hartley, T. M. Leazer and C. D. Klaassen
      Drug Metabolism and Disposition February 2002, 30 (2) 212-219; DOI: https://doi.org/10.1124/dmd.30.2.212

  10. Souid, Abdul-Kader

    1. Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs
      Peter D. Sadowitz, Bradley A. Hubbard, James C. Dabrowiak, Jerry Goodisman, Kirk A. Tacka, Mehmet K. Aktas, Mary J. Cunningham, Ronald L. Dubowy and Abdul-Kader Souid
      Drug Metabolism and Disposition February 2002, 30 (2) 183-190; DOI: https://doi.org/10.1124/dmd.30.2.183

  11. Sugihara, Kazumi

    1. Reductive Metabolism ofp,p′-DDT ando,p′-DDT by Rat Liver Cytochrome P450
      Shigeyuki Kitamura, Yuri Shimizu, Yuko Shiraga, Mayumi Yoshida, Kazumi Sugihara and Shigeru Ohta
      Drug Metabolism and Disposition February 2002, 30 (2) 113-118; DOI: https://doi.org/10.1124/dmd.30.2.113

  12. Sugiyama, Daisuke

    1. Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates
      Daisuke Sugiyama, Hiroyuki Kusuhara, Yoshihisa Shitara, Takaaki Abe and Yuichi Sugiyama
      Drug Metabolism and Disposition February 2002, 30 (2) 220-223; DOI: https://doi.org/10.1124/dmd.30.2.220

  13. Sugiyama, Yuichi

    1. Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates
      Daisuke Sugiyama, Hiroyuki Kusuhara, Yoshihisa Shitara, Takaaki Abe and Yuichi Sugiyama
      Drug Metabolism and Disposition February 2002, 30 (2) 220-223; DOI: https://doi.org/10.1124/dmd.30.2.220

  14. Suthers, B. D.

    1. Conjugation of Desmethylnaproxen in the Rat—A Novel Acyl Glucuronide-Sulfate Diconjugate as a Major Biliary Metabolite
      R. Jaggi, R. S. Addison, A. R. King, B. D. Suthers and R. G. Dickinson
      Drug Metabolism and Disposition February 2002, 30 (2) 161-166; DOI: https://doi.org/10.1124/dmd.30.2.161

T

  1. Tacka, Kirk A.

    1. Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs
      Peter D. Sadowitz, Bradley A. Hubbard, James C. Dabrowiak, Jerry Goodisman, Kirk A. Tacka, Mehmet K. Aktas, Mary J. Cunningham, Ronald L. Dubowy and Abdul-Kader Souid
      Drug Metabolism and Disposition February 2002, 30 (2) 183-190; DOI: https://doi.org/10.1124/dmd.30.2.183

  2. Taskinen, Jyrki

    1. Characterization of Catechol Glucuronidation in Rat Liver
      Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou
      Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199

  3. Thomas, V. Hayden

    1. The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs
      Jasminder Sahi, Eric L. Reyner, Jonathan N. Bauman, Kristina Gueneva-Boucheva, James E. Burleigh and V. Hayden Thomas
      Drug Metabolism and Disposition February 2002, 30 (2) 135-140; DOI: https://doi.org/10.1124/dmd.30.2.135

  4. Tsukamoto, Kunio

    1. Pharmacokinetics and Biliary Excretion of Osaterone Acetate, a New Steroidal Antiandrogen, in Dogs
      Kouichi Minato, Naoyuki Koizumi, Seijirou Honma, Kunio Tsukamoto and Satoshi Iwamura
      Drug Metabolism and Disposition February 2002, 30 (2) 167-172; DOI: https://doi.org/10.1124/dmd.30.2.167

V

  1. Verhoeven, C. H. J.

    1. The in Vivo Human Metabolism of Tibolone
      R. M. E. Vos, S. F. M. Krebbers, C. H. J. Verhoeven and L. P. C. Delbressine
      Drug Metabolism and Disposition February 2002, 30 (2) 106-112; DOI: https://doi.org/10.1124/dmd.30.2.106

  2. Vos, R. M. E.

    1. The in Vivo Human Metabolism of Tibolone
      R. M. E. Vos, S. F. M. Krebbers, C. H. J. Verhoeven and L. P. C. Delbressine
      Drug Metabolism and Disposition February 2002, 30 (2) 106-112; DOI: https://doi.org/10.1124/dmd.30.2.106

W

  1. Walle, Thomas

    1. Oxidation of the Flavonoids Galangin and Kaempferide by Human Liver Microsomes and CYP1A1, CYP1A2, and CYP2C9
      Yoko Otake and Thomas Walle
      Drug Metabolism and Disposition February 2002, 30 (2) 103-105; DOI: https://doi.org/10.1124/dmd.30.2.103

  2. Watanabe, Terumi

    1. Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells
      Yui Yamamoto, Hiroshi Yamazaki, Tomoko Ikeda, Terumi Watanabe, Haruo Iwabuchi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition February 2002, 30 (2) 155-160; DOI: https://doi.org/10.1124/dmd.30.2.155

Y

  1. Yamamoto, Yui

    1. Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells
      Yui Yamamoto, Hiroshi Yamazaki, Tomoko Ikeda, Terumi Watanabe, Haruo Iwabuchi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition February 2002, 30 (2) 155-160; DOI: https://doi.org/10.1124/dmd.30.2.155

  2. Yamazaki, Hiroshi

    1. Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells
      Yui Yamamoto, Hiroshi Yamazaki, Tomoko Ikeda, Terumi Watanabe, Haruo Iwabuchi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition February 2002, 30 (2) 155-160; DOI: https://doi.org/10.1124/dmd.30.2.155

  3. Yokoi, Tsuyoshi

    1. Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells
      Yui Yamamoto, Hiroshi Yamazaki, Tomoko Ikeda, Terumi Watanabe, Haruo Iwabuchi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition February 2002, 30 (2) 155-160; DOI: https://doi.org/10.1124/dmd.30.2.155

  4. Yoshida, Mayumi

    1. Reductive Metabolism ofp,p′-DDT ando,p′-DDT by Rat Liver Cytochrome P450
      Shigeyuki Kitamura, Yuri Shimizu, Yuko Shiraga, Mayumi Yoshida, Kazumi Sugihara and Shigeru Ohta
      Drug Metabolism and Disposition February 2002, 30 (2) 113-118; DOI: https://doi.org/10.1124/dmd.30.2.113
Back to top

In this issue